Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

1.47
Delayed Data
As of 4:00pm ET
 +0.045 / +3.16%
Today’s Change
1.23
Today|||52-Week Range
3.10
-31.31%
Year-to-Date

Today’s Trading

Previous close1.43
Today’s open1.43
Day’s range1.37 - 1.47
Volume24,402
Average volume (3 months)1,514,991
Market cap$264.7M
Data as of 4:00pm ET, 04/03/2020

Growth & Valuation

Earnings growth (last year)+8.97%
Earnings growth (this year)+45.82%
Earnings growth (next 5 years)+42.00%
Revenue growth (last year)+33.20%
P/E ratioNM
Price/Sales6.04
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...-0.12-2.23%
EVFMEvofem Biosciences I...+0.10+2.04%
CODXCo-Diagnostics Inc+3.10+36.90%
SYRSSyros Pharmaceutical...+0.38+6.65%
Data as of 7:26pm ET, 04/03/2020

Financials

Next reporting dateMay 5, 2020
EPS forecast (this quarter)$0.13
Annual revenue (last year)$59.3M
Annual profit (last year)-$66.9M
Net profit margin-112.83%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts